Legionella Testing Market

Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027

Report Code: MD 8150 Aug, 2022, by marketsandmarkets.com

[208 Pages Report] The global legionella testing market is projected to reach USD 439 million by 2027 from USD 296 million in 2022, at a CAGR of 8.2% during the forecast period. Market growth is driven by the rising geriatric population coupled with increasing prevalence of legionella-related illness, and rising demand for rapid diagnostics.

Legionella Testing Market

To know about the assumptions considered for the study, Request for Free Sample Report

Market Dynamics

Driver:  Rapid increase of pneumonia and legionella-related illnesses

According to the European Centre for Disease Prevention and Control (ECDC) (May 2022), Legionnaires’ disease remains an uncommon and mainly sporadic respiratory infection with an overall notification rate of 1.9 cases per 100,000 population for the EU/EEA in 2020. France, Germany, Italy, and Spain accounted for 72% of all notified cases. In addition, according to the US CDC (March 2022), the age-standardized average incidence was 0.48 cases/100,000 population during 1992–2002 compared with 2.71/100,000 in 2018.

Opportunity: Legal requirements for water testing

The Environment Protection Agency (EPA) (October 2021) sets legal limits on over 90 contaminants in the US for drinking water. The legal limit for a contaminant reflects the level that protects human health and that water systems can achieve using the best available technology. EPA rules also set water-testing schedules and methods that water systems must follow. In addition, the Safe Drinking Water Act (SDWA) allows individual states to set and enforce their drinking water standards if the standards are at least as stringent as EPA’s national standards.

Restraint: Lack of reimbursement policies

The major factor restraining the growth of the legionella testing market are inadequate reimbursements. According to MedPAC (Medicare Payment Advisory Commission), medical testing has seen a 40% decline in reimbursement over the last 40 years. This decline and additional budgetary concerns among healthcare systems will be a major obstacle to implementing novel diagnostic techniques in clinical laboratories.

Challenge: Difficulties in detection

The most common cause of Legionnaire’s disease is Legionella pneumophilia serogroup 1, but it can quickly and easily be identified via the urine antigen test. Legionnaire’s disease can also go undetected once a patient is diagnosed with pneumonia. Best practices dictate that all hospital-acquired pneumonia patients be tested for Legionella in hopes of detecting and preventing a possible outbreak.

The legionella testing market is moderately consolidated. The top players— Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Becton, Dickinson, and Company (US), Roche Diagnostics (Switzerland), and Pall Corporation (Danaher) (US)-in the legionella testing market accounted for a combined majority market share in 2021. There is a high degree of competition among the market players. Only major companies can afford high-capital investments as well as the high cost of R&D and manufacturing. This will prevent new entrants from entering this market.

“In 2021, PCR segment accounted for the largest share of the legionella testing market, by test type.”

The legionella testing market is segmented into culture methods, urinary antigen tests, direct fluorescent antibody tests, and PCR. The PCR accounted for the largest share of the legionella testing market in 2021, mainly due to its versatility, speed and simplicity.

In 2021, water testing segment accounted for the largest share in the market, by application.

The legionella testing market has been segmented into water testing, IVD testing, and other applications. In 2021, the water testing segment accounted for the largest share of the legionella testing market. Factor such as the changes in lifestyle around the globe and rising elderly population is driving the growth of the market.

“In 2021, water & other industries segment accounted for the largest share in the market, by end user.”

The legionella testing market has been segmented into hospitals, diagnostic laboratories, water & other industries, and other end users. In 2021, the water & other industries segment accounted for the largest share of the legionella testing market. The strict water treatment regulations, increasing population and urbanization, and the increased need for new water resources is driving the growth of this segment.

“North America is the largest regional market for legionella testing.”

The global legionella testing market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of the legionella testing market. The North American legionella testing market growth can be attributed to the growing elderly population coupled with rising legionella-related illnesses.

Legionella Testing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some key players in the legionella testing market (2022- 2027)

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD Million)

Segments covered

Test type, application, end user, and region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Companies covered

Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), IDEXX Laboratories, Inc. (US), bioMérieux S.A. (France), Becton, Dickinson, and Company (US), Alere, Inc. (US), Eurofins Scientific (Luxembourg), Roche Diagnostics (Switzerland), Pall Corporation (Danaher) (US), Quidel Corporation (US), Eiken Chemical Co., Ltd. (Japan), Hologic, Inc. (US), QIAGEN (Germany), Takara Bio, Inc. (Japan), Environmental Safety Technologies, Inc. (US), Hydrosense (Scotland), Accepta Ltd. (UK), LuminUltra Technologies Ltd. (Canada), Pro-Lab Diagnostics, Inc. (Canada), BioAlert Solutions (Canada), Pacific Water Technology (Australia), Aquacert Ltd. (UK), DTK Water (UK), Sens Solutions (Spain), Genomadix, Inc. (US), and Phigenics, LLC (US).

This report categorizes the legionella testing market into the following segments and subsegments:

By Test Type

  • Culture Methods
  • Urinary Antigen Tests
  • Direct Fluorescent Antibody Tests
  • PCR
    • Motorized Devices
    • Non-Motorized Devices

By Application

  • Water Testing
    • Microbial Culture
    • DFA Stain
    • PCR
  • IVD Testing
    • Blood Culture and Sputum Tests
    • Urinary Antigen Tests
    • DFA Stain
    • PCR
  • Other Applications

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Water & Other Industries
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In December 2021, IDEXX Laboratories, Inc. (US) acquired Reference Laboratories (Finland) to expanded the company’s international reference laboratory presence.
  • In November 2020, LuminUltra Technologies Ltd. (Canada) launched launched GeneCount qPCR, a rapid onsite molecular testing solution.
  • In September 2020, Eurofins Scientific (Luxembourg) acquired SunDream Group (Taiwan) to boost its environmental testing capabilities, as SunDream is the second-largest player in the environmental testing segment in Taiwan.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
          TABLE 1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE
    1.4 YEARS CONSIDERED
    1.5 CURRENCY CONSIDERED
    1.6 LIMITATIONS
    1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 30)
    2.1 RESEARCH DATA
          FIGURE 1 LEGIONELLA TESTING MARKET: RESEARCH DESIGN METHODOLOGY
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                                TABLE 2 KEY DATA FROM PRIMARY SOURCES
                                FIGURE 2 KEY INDUSTRY INSIGHTS
                    2.1.2.2 Breakdown of primary interviews
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (LEGIONELLA TESTING MARKET)
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
                    2.2.1.1 Approach 1: Company revenue estimation approach
                                FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    2.2.1.2 Approach 2: Presentations of companies and primary interviews
                    2.2.1.3 Growth forecast
                    2.2.1.4 CAGR projections
                                FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.2.2 TOP-DOWN APPROACH
                    FIGURE 7 LEGIONELLA TESTING MARKET: TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION
          FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 LIMITATIONS AND RISK ASSESSMENT
          FIGURE 9 LIMITATIONS: LEGIONELLA TESTING MARKET
          TABLE 3 RISK ASSESSMENT: LEGIONELLA TESTING MARKET

3 EXECUTIVE SUMMARY (Page No. - 42)
    FIGURE 10 LEGIONELLA TESTING MARKET, BY TEST TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 LEGIONELLA TESTING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 LEGIONELLA TESTING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 LEGIONELLA TESTING MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 45)
    4.1 LEGIONELLA TESTING MARKET OVERVIEW
          FIGURE 14 GROWING PREVALENCE OF LEGIONELLA-RELATED ILLNESS AND RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH
    4.2 LEGIONELLA TESTING MARKET SHARE, BY TEST TYPE, 2022 VS. 2027
          FIGURE 15 PCR SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027
    4.3 LEGIONELLA TESTING MARKET SHARE, BY APPLICATION, 2022 VS. 2027
          FIGURE 16 WATER TESTING SEGMENT TO HOLD LARGEST MARKET SHARE
    4.4 LEGIONELLA TESTING MARKET SHARE, BY END USER, 2022 VS. 2027
          FIGURE 17 WATER & OTHER INDUSTRIES TO CONTINUE TO DOMINATE MARKET IN 2027
    4.5 LEGIONELLA TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE

5 MARKET OVERVIEW (Page No. - 48)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 19 LEGIONELLA TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising incidence of pneumonia and legionella-related illnesses
                    5.2.1.2 Increasing demand for rapid advanced diagnostic technologies
                    5.2.1.3 Technological advancements in bacterial testing
                    5.2.1.4 Stringent regulations for regular water testing
           5.2.2 RESTRAINTS
                    5.2.2.1 Lack of reimbursement policies
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Opportunities in growing economies
                    5.2.3.2 Legal requirements for water testing
           5.2.4 CHALLENGES
                    5.2.4.1 Difficulties in detection
                    5.2.4.2 Limited awareness in underdeveloped countries
                    5.2.4.3 High health costs associated with Legionella
    5.3 PRICING ANALYSIS
          TABLE 4 AVERAGE SELLING PRICE OF LEGIONELLA TESTING PRODUCTS (2022)
    5.4 PATENT ANALYSIS
          FIGURE 20 PATENT ANALYSIS FOR MOTORIZED LEGIONELLA TESTING DEVICES
          TABLE 5 LIST OF KEY PATENTS
    5.5 VALUE CHAIN ANALYSIS
          FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
    5.6 SUPPLY CHAIN ANALYSIS
          FIGURE 22 LEGIONELLA TESTING MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM/MARKET MAP
          FIGURE 23 LEGIONELLA TESTING MARKET: ECOSYSTEM/MARKET MAP
          TABLE 6 LEGIONELLA TESTING MARKET: ROLE IN ECOSYSTEM
    5.8 PORTER’S FIVE FORCES ANALYSIS
          TABLE 7 LEGIONELLA TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF BUYERS
           5.8.4 BARGAINING POWER OF SUPPLIERS
           5.8.5 DEGREE OF COMPETITION
    5.9 PESTEL ANALYSIS
           5.9.1 POLITICAL FACTORS
           5.9.2 ECONOMIC FACTORS
           5.9.3 SOCIAL FACTORS
           5.9.4 TECHNOLOGICAL FACTORS
           5.9.5 ENVIRONMENTAL FACTORS
           5.9.6 LEGAL FACTORS
    5.10 REGULATORY LANDSCAPE
           TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.10.1 NORTH AMERICA
                    5.10.1.1 US
                    5.10.1.2 Canada
           5.10.2 EUROPE
           5.10.3 ASIA PACIFIC
                    5.10.3.1 Japan
                    5.10.3.2 India
           5.10.4 LATIN AMERICA
                    5.10.4.1 Brazil
                    5.10.4.2 Mexico
           5.10.5 MIDDLE EAST
           5.10.6 AFRICA
    5.11 TRADE ANALYSIS
           5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
                     TABLE 13 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)
                     TABLE 14 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)
    5.12 TECHNOLOGY ANALYSIS
    5.13 KEY CONFERENCES & EVENTS IN 2022–2023
           TABLE 15 LEGIONELLA TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
    5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           FIGURE 24 REVENUE SHIFT IN THE LEGIONELLA TESTING MARKET
    5.15 KEY STAKEHOLDERS & BUYING CRITERIA
           5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF LEGIONELLA TESTING PRODUCTS
                    TABLE 16 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF LEGIONELLA TESTING PRODUCTS
           5.15.2 BUYING CRITERIA
                     FIGURE 26 KEY BUYING CRITERIA FOR LEGIONELLA TESTING PRODUCTS
                     TABLE 17 KEY BUYING CRITERIA FOR LEGIONELLA TESTING PRODUCTS
    5.16 CASE STUDIES

6 LEGIONELLA TESTING MARKET, BY TEST TYPE (Page No. - 75)
    6.1 INTRODUCTION
          TABLE 18 LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
    6.2 PCR
           6.2.1 INCREASED USAGE OF PCR TO SUPPORT MARKET GROWTH
                    TABLE 19 KEY PCR PRODUCTS AVAILABLE IN THE MARKET
                    TABLE 20 LEGIONELLA TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
    6.3 CULTURE METHODS
           6.3.1 HIGHER SPECIFICITY AND SENSITIVITY TO DRIVE MARKET
                    TABLE 21 KEY CULTURE METHODS AVAILABLE IN THE MARKET
                    TABLE 22 LEGIONELLA TESTING MARKET FOR CULTURE METHODS, BY REGION, 2020–2027 (USD MILLION)
    6.4 URINARY ANTIGEN TESTS
           6.4.1 RAPID OUTCOMES TO DRIVE MARKET GROWTH
                    TABLE 23 KEY URINARY ANTIGEN TESTS AVAILABLE IN THE MARKET
                    TABLE 24 LEGIONELLA TESTING MARKET FOR URINARY ANTIGEN TESTS, BY REGION, 2020–2027 (USD MILLION)
    6.5 DIRECT FLUORESCENT ANTIBODY TESTS
           6.5.1 RAPIDITY AND EASE OF USE TO BOOST ADOPTION OF TESTS
                    TABLE 25 LEGIONELLA TESTING MARKET FOR DIRECT FLUORESCENT ANTIBODY TESTS, BY REGION, 2020–2027 (USD MILLION)

7 LEGIONELLA TESTING MARKET, BY APPLICATION (Page No. - 81)
    7.1 INTRODUCTION
          TABLE 26 LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    7.2 WATER TESTING
          TABLE 27 LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 28 LEGIONELLA TESTING MARKET FOR WATER TESTING, BY REGION, 2020–2027 (USD MILLION)
           7.2.1 PCR
                    7.2.1.1 Rapid diagnosis to spur segment growth
                                TABLE 29 WATER TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
           7.2.2 MICROBIAL CULTURE
                    7.2.2.1 Long incubation periods make isolation difficult, affecting adoption of culture techniques
                                TABLE 30 WATER TESTING MARKET FOR MICROBIAL CULTURE, BY REGION, 2020–2027 (USD MILLION)
           7.2.3 DFA STAIN
                    7.2.3.1 High test specificity to drive adoption of DFA staining
                                TABLE 31 WATER TESTING MARKET FOR DFA STAIN, BY REGION, 2020–2027 (USD MILLION)
    7.3 IVD TESTING
          TABLE 32 LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 33 LEGIONELLA TESTING MARKET FOR IVD TESTING, BY REGION, 2020–2027 (USD MILLION)
           7.3.1 URINE ANTIGEN TESTS
                    7.3.1.1 Rapid and early diagnosis capabilities to drive market growth
                                TABLE 34 IVD TESTING MARKET FOR URINE ANTIGEN TESTS, BY REGION, 2020–2027 (USD MILLION)
           7.3.2 PCR
                    7.3.2.1 Emergence of advanced technologies such as qRT-PCR to support market growth
                                TABLE 35 IVD TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
           7.3.3 BLOOD CULTURE & SPUTUM TESTS
                    7.3.3.1 Longer incubation period resulting in lower adoption of blood culture techniques
                                TABLE 36 IVD TESTING MARKET FOR BLOOD CULTURE & SPUTUM TESTS, BY REGION, 2020–2027 (USD MILLION)
           7.3.4 DFA STAIN
                    7.3.4.1 Sensitivity variations affect use of DFA staining in IVD tests
                                TABLE 37 IVD TESTING MARKET FOR DFA STAIN, BY REGION, 2020–2027 (USD MILLION)
    7.4 OTHER APPLICATIONS
          TABLE 38 LEGIONELLA TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)

8 LEGIONELLA TESTING MARKET, BY END USER (Page No. - 92)
    8.1 INTRODUCTION
          TABLE 39 LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.2 WATER & OTHER INDUSTRIES
           8.2.1 STRINGENT REGULATIONS AND GROWING POPULATION TO DRIVE MARKET GROWTH
                    TABLE 40 LEGIONELLA TESTING MARKET FOR WATER & OTHER INDUSTRIES, BY REGION, 2020–2027 (USD MILLION)
    8.3 DIAGNOSTIC LABORATORIES
           8.3.1 HEALTHCARE INFRASTRUCTURE IMPROVEMENTS TO BOOST MARKET GROWTH
                    TABLE 41 LEGIONELLA TESTING MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
    8.4 HOSPITALS
           8.4.1 INCREASING ADOPTION OF DIAGNOSTIC TOOLS TO SUPPORT MARKET GROWTH
                    TABLE 42 LEGIONELLA TESTING MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
    8.5 OTHER END USERS
          TABLE 43 LEGIONELLA TESTING MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)

9 LEGIONELLA TESTING MARKET, BY REGION (Page No. - 97)
    9.1 INTRODUCTION
          TABLE 44 LEGIONELLA TESTING MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.2 NORTH AMERICA
          FIGURE 27 NORTH AMERICA: LEGIONELLA TESTING MARKET SNAPSHOT
          TABLE 45 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 46 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
          TABLE 47 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 48 NORTH AMERICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Strong presence of major market players to drive growth
                                TABLE 49 US: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                                TABLE 50 US: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 51 US: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 52 US: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 53 US: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Rising incidence of lifestyle diseases to drive market growth
                                TABLE 54 CANADA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                                TABLE 55 CANADA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 56 CANADA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 57 CANADA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 58 CANADA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.3 EUROPE
          TABLE 59 EUROPE: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 60 EUROPE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
          TABLE 61 EUROPE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 62 EUROPE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany dominates Legionella testing market in Europe
                                TABLE 63 GERMANY: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                                TABLE 64 GERMANY: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 65 GERMANY: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 66 GERMANY: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 67 GERMANY: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Growing number of accredited diagnostic laboratories to propel market growth
                                TABLE 68 UK: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                                TABLE 69 UK: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 70 UK: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 71 UK: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 72 UK: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Rising R&D expenditure and increasing demand for early diagnosis to drive market growth
                                TABLE 73 FRANCE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                                TABLE 74 FRANCE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 75 FRANCE: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 76 FRANCE: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 77 FRANCE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Adoption of advanced diagnostic technologies to drive market growth
                                TABLE 78 ITALY: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                                TABLE 79 ITALY: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 80 ITALY: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 81 ITALY: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 82 ITALY: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Rising geriatric population to drive market growth
                                TABLE 83 SPAIN: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                                TABLE 84 SPAIN: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 85 SPAIN: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 86 SPAIN: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 87 SPAIN: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 88 ROE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                    TABLE 89 ROE: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 90 ROE: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 91 ROE: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 92 ROE: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.4 ASIA PACIFIC
          FIGURE 28 APAC: LEGIONELLA TESTING MARKET SNAPSHOT
          TABLE 93 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 94 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
          TABLE 95 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 96 ASIA PACIFIC: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 Growing public access to modern healthcare to drive market growth
                                TABLE 97 CHINA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                                TABLE 98 CHINA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 99 CHINA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 100 CHINA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 101 CHINA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Universal healthcare reimbursement policy to drive market growth
                                TABLE 102 JAPAN: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                                TABLE 103 JAPAN: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 104 JAPAN: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 105 JAPAN: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 106 JAPAN: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Increasing private & public investments in healthcare to drive market growth
                                TABLE 107 INDIA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                                TABLE 108 INDIA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 109 INDIA: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 110 INDIA: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 111 INDIA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 112 ROAPAC: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                    TABLE 113 ROAPAC: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 114 ROAPAC: LEGIONELLA TESTING MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 115 ROAPAC: LEGIONELLA TESTING MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 116 ROAPAC: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.5 LATIN AMERICA
           9.5.1 RISING HEALTHCARE EXPENDITURE TO DRAW FOREIGN PLAYERS
                    TABLE 117 LATIN AMERICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                    TABLE 118 LATIN AMERICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 119 LATIN AMERICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 RISING ACCESS TO ADVANCED TECHNOLOGIES AND GROWING INVESTMENTS TO SUPPORT MARKET GROWTH
                    TABLE 120 MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
                    TABLE 121 MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 122 MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY END USER, 2020–2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 136)
     10.1 OVERVIEW
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE LEGIONELLA TESTING MARKET
                        TABLE 123 STRATEGIC DEVELOPMENTS REPORTED
     10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
             FIGURE 29 REVENUE SHARE ANALYSIS OF TOP PLAYERS
     10.4 MARKET SHARE ANALYSIS
             10.4.1 LEGIONELLA TESTING MARKET
                        FIGURE 30 LEGIONELLA TESTING MARKET SHARE, BY KEY PLAYER (2021)
                        TABLE 124 LEGIONELLA TESTING MARKET: DEGREE OF COMPETITION
     10.5 COMPANY EVALUATION MATRIX
             10.5.1 LIST OF EVALUATED VENDORS
             10.5.2 STARS
             10.5.3 EMERGING LEADERS
             10.5.4 PERVASIVE PLAYERS
             10.5.5 PARTICIPANTS
                        FIGURE 31 LEGIONELLA TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
     10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                        FIGURE 32 LEGIONELLA TESTING MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
     10.7 COMPETITIVE BENCHMARKING
             10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS
                        FIGURE 33 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN LEGIONELLA TESTING MARKET
                        TABLE 125 LEGIONELLA TESTING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
                        TABLE 126 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
                        TABLE 127 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
                        TABLE 128 LEGIONELLA TESTING MARKET: DETAILED LIST OF KEY START-UPS/SMES
     10.8 COMPETITIVE SCENARIO
             10.8.1 PRODUCT LAUNCHES
                        TABLE 129 LEGIONELLA TESTING MARKET: KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
             10.8.2 DEALS
                        TABLE 130 LEGIONELLA TESTING MARKET: KEY DEALS
             10.8.3 OTHER DEVELOPMENTS
                        TABLE 131 LEGIONELLA TESTING MARKET: OTHER DEVELOPMENTS

11 COMPANY PROFILES (Page No. - 148)
(Business Overview, Products Offered, Recent Developments, MnM View SWOT analysis) *
     11.1 KEY PLAYERS
             11.1.1 INDUSTRIAL/WATER
                        11.1.1.1 Thermo Fisher Scientific
                                      TABLE 132 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
                                      FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
                        11.1.1.2 Merck KGAA
                                      TABLE 133 MERCK KGAA: BUSINESS OVERVIEW
                                      FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2021)
                        11.1.1.3 Bio-Rad Laboratories
                                      TABLE 134 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
                                      FIGURE 36 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2021)
                        11.1.1.4 IDEXX Laboratories
                                      TABLE 135 IDEXX LABORATORIES: BUSINESS OVERVIEW
                                      FIGURE 37 IDEXX LABORATORIES: COMPANY SNAPSHOT (2021)
                        11.1.1.5 Biomérieux SA
                                      TABLE 136 BIOMÉRIEUX SA: BUSINESS OVERVIEW
                                      FIGURE 38 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021)
                        11.1.1.6 Becton, Dickinson and Company
                                      TABLE 137 BECTON, DICKINSON, AND COMPANY: BUSINESS OVERVIEW
                                      FIGURE 39 BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT (2021)
                        11.1.1.7 Eurofins Scientific
                                      TABLE 138 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
                                      FIGURE 40 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
                        11.1.1.8 Takara Bio
                                      TABLE 139 TAKARA BIO: BUSINESS OVERVIEW
                                      FIGURE 41 TAKARA BIO: COMPANY SNAPSHOT (2021)
                        11.1.1.9 Eiken Chemical
                                      TABLE 140 EIKEN CHEMICAL: BUSINESS OVERVIEW
                                      FIGURE 42 EIKEN CHEMICAL: COMPANY SNAPSHOT (2021)
                        11.1.1.10 Qiagen
                                      TABLE 141 QIAGEN: BUSINESS OVERVIEW
                                      FIGURE 43 QIAGEN: COMPANY SNAPSHOT (2021)
                        11.1.1.11 Genomadix
                                      TABLE 142 GENOMADIX, INC.: BUSINESS OVERVIEW
     11.2 OTHER PLAYERS
             11.2.1 INDUSTRIAL/WATER
                        11.2.1.1 Pall Corporation (DANAHER)
                        11.2.1.2 Phigenics, Llc
                        11.2.1.3 Environmental safety technologies
                        11.2.1.4 Hydrosense
                        11.2.1.5 Accepta
                        11.2.1.6 Luminultra technologies
                        11.2.1.7 Bioalert solutions
                        11.2.1.8 Aquacert
                        11.2.1.9 Pacific water technology
                        11.2.1.10 DTK Water
                        11.2.1.11 Sens solutions
             11.2.2 HEALTHCARE
                        11.2.2.1 Alere (ABBOTT)
                                      TABLE 143 ABBOTT: BUSINESS OVERVIEW
                                      FIGURE 44 ABBOTT: COMPANY SNAPSHOT (2021)
                        11.2.2.2 Roche Diagnostics
                                      TABLE 144 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW
                                      FIGURE 45 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2021)
                        11.2.2.3 Hologic
                                      TABLE 145 HOLOGIC: BUSINESS OVERVIEW
                                      FIGURE 46 HOLOGIC: COMPANY SNAPSHOT (2021)
                        11.2.2.4 Quidel Corporation
                                      TABLE 146 QUIDEL CORPORATION: BUSINESS OVERVIEW
                                      FIGURE 47 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
                        11.2.2.5 Pro-Lab Diagnostics

*Details on Business Overview, Products Offered, Recent Developments, MnM View, SWOT analysis might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 201)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 CUSTOMIZATION OPTIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the legionella testing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.

The following is a breakdown of the primary respondents:

Legionella Testing Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the legionella testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the legionella testing market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Global Legionella testing Market Size: Top-Down Approach

Legionella Testing Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, segment, and forecast the global legionella testing market by test type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall legionella testing market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as product launches, agreements, partnerships, and acquisitions in the legionella testing market
  • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

Legionella testing market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa

Company profiles

Additional five company profiles of players operating in the legionella testing market.

Legionella Testing Market Size,  Share & Growth Report
Report Code
MD 8150
Published ON
Aug, 2022
Choose License Type
BUY NOW
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status